Lv1
20 积分 2022-02-17 加入
Posterior Reversible Encephalopathy Syndrome
1天前
已完结
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
6个月前
已完结
Comparison of obinutuzumab and rituximab for treating primary membranous nephropathy
7个月前
已完结
A novel approach to induce early remission in high-risk primary membranous nephropathy
8个月前
已完结
Quantification of urinary podocyte‐derived migrasomes for the diagnosis of kidney disease
8个月前
已完结
Obinutuzumab in untreated primary membranous nephropathy: An observational case series
10个月前
已完结
Obinutuzumab in the treatment of PLA2R-positive membranous glomerulonephritis resistant to treatment
11个月前
已完结
ATAD3B is a mitophagy receptor mediating clearance of oxidative stress-induced damaged mitochondrial DNA
3年前
已完结
皖公网安备34019202002308
